Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol

The introduction of anti-amyloid therapies for Alzheimer’s disease (AD), such as lecanemab (Lequembi ®), which was recently approved in Korea, necessitates careful monitoring for amyloid-related imaging abnormalities (ARIA) using brain MRI. To optimize ARIA monitoring in Korean clinical settings,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jimin Kim, Eunhee Kim, Mina Park, Yun Jung Bae, Chong Hyun Suh, Sung-Hye You, Younghee Yim, Ho-Joon Lee, Jin Wook Choi, Se Won Oh, Won-Jin Moon
Format:	Article
Language:	English
Published:	The Korean Society of Radiology 2025-01-01
Series:	Journal of the Korean Society of Radiology
Subjects:	alzheimer’s disease amyloid-related imaging abnormalities anti-amyloid monoclonal antibodies magnetic resonance imaging monitoring
Online Access:	https://doi.org/10.3348/jksr.2024.0147
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
by: Byeong-Hyeon Kim, et al.
Published: (2025-01-01)

Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01)

Targeting Soluble Amyloid Oligomers in Alzheimer’s Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration
by: Manuel Menendez-Gonzalez
Published: (2025-01-01)

A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
by: Naoya Nakashima, et al.
Published: (2022-06-01)

Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer's disease
by: Wenxuan Wang, et al.
Published: (2025-02-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

Relationship between regional relative theta power and amyloid deposition in mild cognitive impairment: an exploratory study
by: Jaesub Park, et al.
Published: (2025-02-01)

Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits
by: Mizuki Ida, et al.
Published: (2022-06-01)

Predicting amyloid proteins using attention-based long short-term memory
by: Zhuowen Li
Published: (2025-02-01)

Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
by: Aixin Ni, et al.
Published: (2023-09-01)

Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
by: Hayder M. Al-Kuraishy, et al.
Published: (2025-02-01)

Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
by: Shahram Darabi, et al.
Published: (2025-06-01)

Effect of Simple Oral Dental Extraction on Systemic Serum Amyloid A Concentrations in Horses
by: Amelia E. Sidwell, et al.
Published: (2024-11-01)

Progress in Preparation, Functional Characteristics and Application of Soybean Protein Amyloid-like Fibrils
by: ZHU Xiuqing, HAN Tianlu, LIU Jiyuan, GUO Ruqi, ZHU Ying, HUANG Yuyang, LIU Linlin
Published: (2025-02-01)

Higher detectability of amyloid with phenol Congo red compared with alkaline Congo red
by: Marta Legatowicz-Koprowska, et al.
Published: (2024-11-01)

Saponins Effect on Human Insulin Amyloid Aggregation
by: Eleonora Mari, et al.
Published: (2024-12-01)

Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease
by: Longsheng Xie, et al.
Published: (2025-01-01)

Preparation and Properties of Oat Protein Amyloid Aggregate-Sodium Carboxymethyl Cellulose Composite Film
by: Liangliang WANG, et al.
Published: (2025-02-01)

Effect of Amyloid Protein Fibrils on the Quality of Frozen Minced Meat
by: WU Xiao, LIU Zhanghanyu, LIU Shuo, WANG Mengting, SUN Xiaoshuai, LI Teng
Published: (2024-12-01)

Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
by: Raliat O. Abioye, et al.
Published: (2021-05-01)

The question of strains in AA amyloidosis
by: Gunilla T. Westermark, et al.
Published: (2025-01-01)

Mitral and tricuspid stenosis caused by light chain cardiac amyloid deposition
by: Varinder K. Randhawa, et al.
Published: (2020-06-01)

Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01)

Mesenchymal stem cell‐derived exosomes mitigate amyloid β‐induced retinal toxicity: Insights from rat model and cellular studies
by: Amanda Qarawani, et al.
Published: (2025-01-01)

Balancing inflammation: the specific roles of serum amyloid A proteins in sterile and infectious diseasese
by: Tirthankar Mohanty, et al.
Published: (2025-02-01)

Hypertension moderates the relationship between plasma beta-amyloid and cognitive impairment: a cross-sectional study in Xi’an, China
by: Ziyu Liu, et al.
Published: (2025-01-01)

Study on the Therapeutic Effects of Bisdemethoxycurcumin on a Cerebral Amyloid Angiopathy Mouse Model Established via Chronic Treatment With Five Vascular Risk Factors
by: Shudong Lin, et al.
Published: (2025-01-01)

In silico study about β-amyloid’s role in Alzheimer’s disease and glaucoma and prediction of its interactions with glaucoma related proteins
by: Nancy Maurya
Published: (2023-08-01)

Machine learning models for dementia screening to classify brain amyloid positivity on positron emission tomography using blood markers and demographic characteristics: a retrospective observational study
by: Noriyuki Kimura, et al.
Published: (2025-01-01)

Prion meeting 2023: implications of a growing field
by: Tiago F. Outeiro, et al.
Published: (2024-12-01)

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01)

Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist
by: So Yeong Jeong, et al.
Published: (2025-01-01)

Mutations in human prion-like domains: pathogenic but not always amyloidogenic
by: Andrea Bartolomé-Nafría, et al.
Published: (2024-12-01)

Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
by: Marilena K. Theodoropoulou, et al.
Published: (2024-12-01)

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
by: Fumi Oike, et al.
Published: (2022-06-01)

Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer’s disease diagnosis and therapeutic targets
by: Letian Huang, et al.
Published: (2025-12-01)

Thioflavin-T: application as a neuronal body and nucleolar stain and the blue light photo enhancement effect
by: Jin-Hong Min, et al.
Published: (2024-10-01)

Identification of the Highly Polymorphic Prion Protein Gene (<i>PRNP</i>) in Frogs <i>(Rana dybowskii</i>)
by: Chang-Su Han, et al.
Published: (2025-01-01)

Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
by: Eva Schlein, et al.
Published: (2024-12-01)

Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01)